2019 China Japan advanced medical and new drug R & D Summit Forum and the third round of achievement transformation Conference

"2019 China Japan advanced medical and new drug R & D summit and achievement transformation conference" will be held in Chengdu on November 10, 2019 (Registration No.9) The conference was jointly organized by the Kobe Research Center for medical innovation (TRI) and Sichuan International Association for the promotion of medical exchanges, and received guidance and strong support from many departments in the province In addition to the summit forum, the conference will also solemnly launch more than 1000 achievements and products of the most advanced medical technology, new drug research and development between China and Japan for transformation and investment, including more than 400 regenerative medical products such as stem cell therapy and biomaterials, various immunotherapy and gene therapy and other new drug products provided by Japan, which are under development or have completed clinical trials, The conference will provide a platform for doctors and scientists, entrepreneurs and investors from China and Japan to demonstrate, exchange and invest results With the theme of "dialogue with top experts, gathering leading achievements, sharing investment opportunities and promoting industrial development", the conference has invited more than 1000 Chinese and Japanese government officials, experts, scholars, entrepreneurs, as well as representatives of well-known universities, scientific research institutions, investment institutions and relevant enterprises Among them, Chinese guests at the meeting include famous experts, entrepreneurs and investors such as the national health and Health Commission, the State Food and drug administration, Sichuan provincial and municipal leaders and many academicians; Japanese guests include the head of the Japan food and drug administration, Nobel Prize winners, dozens of top experts in the field of biological medicine research and development and dozens of large Japanese pharmaceutical enterprises Nearly 200 large-scale investment institutions and pharmaceutical enterprises at home and abroad will attend the conference Now we sincerely invite representatives from all walks of life engaged in medicine and related fields at home and abroad to attend the conference Dialogue with top experts and gather leading achievements Sharing investment opportunities and promoting industrial development November 10, 2019 (check in No.9) Shangri la Hotel Chengdu Kobe translational medicine research center (TRI) Sichuan International Medical Exchange Promotion Association Sichuan health committee Sichuan Drug Administration Sichuan Association of science and technology West China Hospital of Sichuan University Industrial Technology Research Institute of Sichuan University State Key Laboratory of Biotherapy, West China Hospital, Sichuan University Center for Disease Molecular Network frontier science, Sichuan University Chengdu Frontier Medical Center Western Sichuan Medical Technology Transfer Center China Pharmaceutical Biotechnology Association Chengdu hi tech Zone biological industry experts Federation Daily economic news Chengdu Economic and Information Bureau Chengdu hi tech Zone Management Committee Wenjiang District People's Government Wuhou District People's Government Pengzhou Municipal People's Government Chengdu Tianfu New Area Management Committee Chengdu Industrial Investment Group Co., Ltd Kobe translational medicine research center, Japan Translational Research Center for Medical Innovation（TRI） The center is a semi official organization under the direct jurisdiction of the Japan drug administration and is managed by the Ministry of culture, science and technology of Japan and Kobe City The current president is Professor Ben Shuyou (Kyoto University), inventor of PD-1 and winner of Nobel Prize in 2018 The former Fukushima professor of Kyoto University serves as the center director The center manages thousands of projects such as various kinds of stem cell therapy and biomaterials, immunotherapy and gene therapy, and clinical trials of new drugs in Japan, of which more than 400 have entered clinical trials In recent years, tri has actively promoted mutually beneficial cooperation and achievement transformation with local governments, universities and research institutions, pharmaceutical enterprises and investment institutions, and actively promoted industrial upgrading of Chinese enterprises Sichuan Medical Promotion Association is a first-class association under the charge of Sichuan Association for science and technology Wei Yuquan, academician of the Chinese Academy of Sciences and director of the State Key Laboratory of biotherapy of West China Hospital of Sichuan University, serves as the president Its member units include West China Hospital of Sichuan University, the second Hospital of West China, West China Stomatology Hospital, State Key Laboratory of biotherapy of Sichuan University, Chengdu University of traditional Chinese medicine, etc Medical (Academic) institutes and biological and pharmaceutical research institutions of many universities cover almost all three-level medical institutions in the province and regional medical centers in cities and prefectures Member units have a strong ability of research and development and transformation of biomedical achievements, and hundreds of projects enter into investment transformation every year President of tri, 2018 Nobel Prize winner Tasuku Honjo, born in 1942 in Kyoto, Japan, graduated from Kyoto University, immunologist Winner of the 2018 Nobel Prize in physiology or medicine, foreign academician of the National Academy of Sciences of the United States, and member of the Japanese Academy of Sciences Currently, he is a special professor of higher Research Institute of Kyoto University, President of legal person of Shizuoka public university, and a cultural contributor Director of Kobe translational medicine research center, Japan Masanori Fukushima, translation research center for medical, Kobe, Japan In the past 25 years, he has been a oncologist in Aichi Cancer Center and Kyoto University Hospital He has rich experience in the field of specialty Dr Fukushima is also engaged in the practice and broadcasting of standard cancer treatment and has participated in the reform of Japanese medical system So far, he has been actively working for the establishment of Japanese clinical treatment and clinical science knowledge base Make contributions Academician of Chinese Academy of Sciences, cancer therapy and Wei Yuquan, academician of the Chinese Academy of Sciences, director of the clinical oncology center of West China Hospital of Sichuan University and director of the State Key Laboratory of Biotherapy, President of China Medical Biotechnology Association, former vice president of Sichuan University, former vice president of China Medical Association Co editor of signal transformation and targeted therapy, deputy editor of human gene therapy, deputy editor of current molecular medicine and editorial board of several SCI magazines Mainly from the basic research, key technology development, product development and clinical treatment of Biotherapy, more than 300 SCI papers have been published in various international journals, more than 60 patents have been applied for, and many innovative drugs have been developed and transferred to enterprises, which are under joint development Each registered participant will be provided with a free display board for exhibition and exchange of results, which will be displayed publicly on the conference website You are welcome to actively provide projects and results that need to be displayed and exchanged Please pay attention to the "WeChat official account of the advanced medical achievements transformation platform in China and Japan" to see more details of the results (quasi) Time: November 9, 2019 Venue: Shangri La Hotel, Chengdu The badge is the sign of the delegates Security is set up throughout the meeting, Red Badge: VIP guests Green Badge: delegates Blue Badge: staff Yellow Badge: media personnel For breakfast, please have a meal in the hotel where you stay; For lunch and dinner, please refer to the designated time on the meal voucher All delegates and guests who have successfully registered for the meeting, Hejiang hall on the first floor of Shangri La Hotel Opening hours: 12:00-22:00, November 9 Exhibition venue Exhibition time: 9:00-18:00 on November 10 It is forbidden to distribute or During the meeting, delegates must wear badges to enter and exit the venue; During the meeting, it is strictly prohibited to record the presentation slides, video presentations or display pictures by means of shooting, photographing, recording, copying, etc Please put drinks and lunch boxes into the dustbin consciously to keep the venue clean; During the meeting, please put your mobile phone in a quiet or vibrating state to keep the venue quiet; Please take good care of your finance and safety during the meeting More conference information, live conference (computer end) Wu Zhenhao 188 2805 0676 Luyue 134 3989 3959 Cheng Lei 139 8046 5330 Deng YuanJu 1842831 7948 He bingxia 182 0023 4049 Liu Yuhang 135 4077 4606 Liu Mei 135 4131 5807 Yuan Sha 183 2802 5785 Wang Ping 180 8101 8794 Liu Dezhi 1858362 5773 Li tingran 152 0125 6022 Address of organizing committee: Bus stop near Shangri La Hotel: Bus lines near Shangri La Hotel: Jiuyanqiao West: 56a, 56, 68, 82, 112, 343 Cizhu road crossing, Zhimin Road: No 256, No 1022, No 193 and No 1130 Jiuyanqiao North: No.3, No.27, No.34, No.72, No.74 and No.92 Chengdu Shuangliu Airport Shangri La Hotel The time is short: Walking less: Estimate of taxi to Shangri La Hotel The taxi fare of Shangri La Hotel, terminal 2 of Shuangliu Airport, is estimated to be 70 yuan.